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Abstract
 
Although CD8 T cell–mediated immunosuppression has been a well-known phenomenon
during the last three decades, the nature of primary CD8 T suppressor cells and the mechanism
underlying their generation remain enigmatic. We demonstrated that naive CD8 T cells
primed with allogeneic CD40 ligand–activated plasmacytoid dendritic cells (DC)2 differenti-
ated into CD8 T cells that displayed poor secondary proliferative and cytolytic responses. By
contrast, naive CD8 T cells primed with allogeneic CD40 ligand–activated monocyte-derived
DCs (DC1) differentiated into CD8 T cells, which proliferated to secondary stimulation and
killed allogeneic target cells. Unlike DC1-primed CD8 T cells that produced large amounts of
interferon (IFN)-
 
 
 
 upon restimulation, DC2-primed CD8 T cells produced significant
amounts of interleukin (IL)-10, low IFN-
 
 
 
, and no IL-4, IL-5, nor transforming growth factor
(TGF)-
 
 
 
. The addition of anti–IL-10–neutralizing monoclonal antibodies during DC2 and
CD8 T cell coculture, completely blocked the generation of IL-10–producing anergic CD8 T
cells. IL-10–producing CD8 T cells strongly inhibit the allospecific proliferation of naive CD8
T cells to monocytes, and mature and immature DCs. This inhibition was mediated by IL-10,
but not by TGF-
 
 
 
. IL-10–producing CD8 T cells could inhibit the bystander proliferation of
naive CD8 T cells, provided that they were restimulated nearby to produce IL-10. IL-10–pro-
ducing CD8 T cells could not inhibit the proliferation of DC1-preactivated effector T cells.
This study demonstrates that IL-10–producing CD8 T cells are regulatory T cells, which pro-
vides a cellular basis for the phenomenon of CD8 T cell–mediated immunosuppression and
suggests a role for plasmacytoid DC2 in immunological tolerance.
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Introduction
 
The concept of T lymphocyte–mediated immunosuppression
was established 30 yr ago, after the observation that immuno-
logical tolerance could be induced in naive animals upon
the transfer of antigen-primed T lymphocytes (1, 2). The
recent identification of regulatory CD4 T cell subsets de-
fined by their surface phenotype (CD45RC
 
low
 
 in rat,
 
CD45RB
 
low
 
CD25
 
 
 
 in mice), their capacity to produce
IL-10, or a combination of IL-10, IL-4, and TGF-
 
 
 
, finally
provided a cellular basis for this immunological paradigm
(3–7). A role for CD8 T cells in the in vivo suppression of
self-reactive T cells has also been described (8–10). CD8 T
cells may mediate antigen-specific immunosuppression by
killing CD4 T helper cells (11, 12) or antigen presenting
cells (13), or by noncytolytic pathways that have not been
clearly defined. Although a number of noncytolytic CD8 T
cell clones with inhibitory activity have been described
(14–17), the nature of the primary CD8 T suppressor cells
and the mechanism underlying their generation still remain
elusive (18–20). Dendritic cells (DC)
 
*
 
 were shown to in-
duce Th1 versus Th2 differentiation depending on their
maturation stage, the type and duration of activation, and
DC subsets (21–24). We have previously shown that ma-
ture plasmacytoid DC2 activated by CD40 ligand either for
24 h or 6 d induced Th2 differentiation, whereas mature
monocyte-derived DC1 activated by CD40 ligand for 24 h
induced Th1 differentiation (25). Here we investigate the
role of DC1 and DC2 in activation and differentiation of
naive CD8 T cells. We show that in contrast to DC1,
which induce the differentiation of naive CD8 T cells into
CTL, DC2 induce a population of CD8 T regulatory cells
that are anergic, noncytolytic, and capable of inhibiting pri-
mary T cell responses through the production of IL-10.
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*
 
Abbreviations used in this paper:
 
 DC, dendritic cell(s); Tr, regulatory T. 
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Plasmacytoid DC2 Induce CD8 T Regulatory Cells
 
Materials and Methods
 
Generation of DC1 from Monocytes.
 
Mononuclear cells were
isolated from peripheral blood of healthy donors by Ficoll-
Hypaque centrifugation (Amersham Pharmacia Biotech). Cells
were then centrifuged on 52% Percoll gradient (Amersham Phar-
macia Biotech) for 20 min at 400 g. Residual T, B, and NK cells,
as well as erythrocytes were depleted by using mouse anti-CD2
(OKT11), anti-CD3 (OKT3), anti-CD8 (Leu-2a), anti-CD19
(Leu-12), anti-CD20 (Leu-16), anti-CD56 (Leu-19), and anti–
glycophorin A (10F7MN) mAbs, and magnetic beads coated with
goat anti–mouse IgG (Dynabeads M-450; Dynal). Isolated
CD14
 
 
 
 monocytes (purity 
 
 
 
90%) were cultured in RPMI 1640
(Biowhittaker) and supplemented with 10% FCS (Biowhittaker),
2 mM 
 
l
 
-glutamine, 10 mM Hepes, 1 mM sodium pyruvate, pen-
icillin G, and streptomycin (Life Technologies) in the presence of
100 ng/ml GM-CSF and 200 U/ml of IL-4 (Schering-Plough
Research Institute) for 5 d. The resulting immature DC1 were
washed and cultured for 24 h with CD40 ligand–transfected L
cells (irradiated at 5,500 rad) to obtain mature DC1 (25).
 
Generation of DC2 from CD4
 
 
 
CD11c
 
 
 
lineage
 
 
 
 Blood Precur-
sors.
 
T, B, and NK cells, monocytes, and erythrocytes were de-
pleted from blood mononuclear cells by using mouse anti-CD3,
anti-CD19, anti-CD16 (Immunotech), anti-CD14 (RPA-M1),
and anti–glycophorin A mAbs, and magnetic beads coated with
goat anti–mouse IgG. The resulting cells were stained with PE-
Cy5–conjugated anti-CD4 (Immunotech), PE-conjugated anti-
CD11c (Becton Dickinson), and a cocktail of FITC-conjugated
anti-CD3, anti-CD14, anti-CD16, and anti-CD20 mAbs (Bec-
ton Dickinson). The CD4
 
 
 
CD11c
 
 
 
CD3
 
 
 
CD14
 
 
 
CD16
 
 
 
CD20
 
 
 
cells (DC2 precursors) were isolated by cell sorting (26). These
cells (purity 
 
 
 
99%) were cultured with 10 ng/ml of IL-3 (R&D
Systems) in the presence of irradiated CD40 ligand–transfected L
cells for 6 d, or with IL-3 alone for 5 d, followed by a 24-h stim-
ulation with CD40 ligand–transfected L cells (25).
 
Isolation of Naive CD8 T Lymphocytes from Adult Blood.
 
Naive
CD8 T cells were enriched from peripheral blood mononuclear
cells by immunomagnetic depletion using mouse anti-CD4, anti-
CD14, anti-CD16, anti-CD19, anti–HLA-DR, and anti-CD45RO
mAb, followed by magnetic beads coated with goat anti–mouse
IgG. These cells were stained with PE-Cy5–conjugated anti-
CD45RA, PE-conjugated anti-CD27 (BD PharMingen), and a
cocktail of FITC-conjugated anti-CD4, anti–TCR-
 
  
 
, anti-
CD14, anti-CD16, and anti-CD20 mAbs (Becton Dickinson).
CD27
 
 
 
CD45RA
 
 
 
lineage
 
 
 
 were isolated by fluorescence-
activated cell sorting and were 
 
 
 
98% CD8
 
 
 
 T cells. CD8
 
 
 
CD27
 
 
 
CD45RA
 
 
 
 have been previously described as naive CD8
T cells (27).
 
Primary Allogeneic CD8 T Cell Cultures.
 
4 
 
 
 
 10
 
4
 
 freshly iso-
lated CD8
 
 
 
CD27
 
 
 
CD45RA
 
 
 
 T cells were cultured for 6 d
with 10
 
4
 
 allogeneic DC1 or DC2 in 200 
 
 
 
l of Yssel’s medium
(Irvine Scientific) containing 10% FCS in 96-well U-bottom
culture plates. IL-2 (10 U/ml) was added at day 2 of culture.
Naive CD8 T cells were also cultured with plate-bound anti-
CD3 mAb SPV-T3b and 1 
 
 
 
g/ml of soluble anti-CD28 mAb
L293.1 (Becton Dickinson). In some experiments, recombinant
human IL-12 (2 ng/ml; R&D Systems), neutralizing anti–IL-12
mAb AB-219-NA (10 
 
 
 
g/ml; R&D Systems), or neutralizing
anti–IL-10 mAb 12G8 (10 
 
 
 
g/ml; DNAX) were added to the
cultures.
 
Proliferation Assays.
 
Primary and secondary proliferative T
cell responses were assessed by stimulating 4 
 
 
 
 10
 
4
 
 T cells with
10
 
4
 
 CD40 ligand–activated DC1 or DC2 in 96-well round-bot-
tom plates without the addition of IL-2. During the last 12 h of
culture, 1 
 
 
 
Ci of [
 
3
 
H]thymidine was added to each well and cel-
lular incorporation was determined.
 
Cytotoxicity Assay.
 
After 6 d, CD8 T cells, which represented
 
 
 
99% of viable cells in cultures, were tested for the capacity to
lyse 
 
51
 
Cr-labeled allogeneic or autologous targets. Target cells in-
cluded B cells isolated by the positive selection of CD19
 
 
 
 cells
(purity 
 
 
 
95%) and activated with CD40 ligand–transfected L
cells and IL-4 (100 U/ml) for 6–12 d (28). The assay was per-
formed by using 2,500 
 
51
 
Cr-labeled target cells per well and incu-
bated with the indicated effectors at 37
 
 
 
C for 5 h before collect-
ing the supernatants and counting in a gamma counter. We used
Triton X to determine the maximum lysis and target cells alone
to determine the spontaneous lysis. The percentage of lysis was
calculated as follows: (spontaneous cpm 
 
 
 
 experimental cpm)/
spontaneous cpm.
 
Analysis of Cytokine Production.
 
To test their capacity to se-
crete cytokines, T cells (10
 
6
 
/ml) were restimulated with plate-
bound anti-CD3 mAb (10 
 
 
 
g/ml) plus 1 
 
 
 
g/ml of soluble anti-
CD28 mAb for 24 h. IFN-
 
 
 
, TNF-
 
 
 
, IL-4, IL-5, and IL-10 in
the culture supernatants were measured by Quantikine ELISA
kits (R&D Systems). For flow cytometry analysis of intracellular
cytokines, T cells were restimulated with plate-bound anti-CD3
mAb plus soluble anti-CD28 mAb, or with 50 ng/ml PMA plus
500 ng/ml ionomycin. After 2.5 h, 10 
 
 
 
g/ml of Brefeldin A (Ep-
icentre) was added and the cells were cultured for an additional
2.5 h. Harvested cells were fixed with 2% formaldehyde (Sigma-
Aldrich) and permeabilized with PBS supplemented with 2%
FCS, 0.1% NaN3, and 0.5% saponin (Sigma-Aldrich). The cells
were stained with fluorochrome-labeled anti–IFN-
 
 
 
 mAb 4S.B3,
anti–IL-10 mAb, and anti–IL-4 mAb (BD PharMingen).
 
Suppressor Assay.
 
In direct coculture experiments 4 
 
 
 
 10
 
4
 
naive CD8 T cells were cultured in 96-well round-bottom plates
with 4 
 
 
 
 10
 
4
 
 allogeneic APC (monocytes, immature DC1, or
mature DC1) in the presence of graded doses of DC2-primed
CD8 regulatory T (Tr) cells. After 5 d of culture 1 
 
 
 
/Ci of
[
 
3
 
H]thymidine was added to each well and cellular incorporation
was determined after 12 h. In some experiments, neutralizing
anti–IL-10 mAb (10 
 
 
 
g/ml, 12G8) or anti–TGF-
 
 
 
1, -
 
 
 
2, -
 
 
 
3
mAb (10 
 
 
 
g/ml; catalog number 80-1835-03; Genzyme) that
neutralize human TGF-
 
 
 
1 and TGF-
 
 
 
2, was added at the begin-
ning of the assay. Transwell experiments were performed in 24-
well plates. 5 
 
 
 
 10
 
5
 
 CD8 Tr cells plus 5 
 
 
 
 10
 
5
 
 APC were placed
in transwell chambers separated from a coculture of 5 
 
 
 
 10
 
5
 
 naive
CD8 T cells plus 5 
 
 
 
 10
 
5
 
 APC by a 0.2-
 
 
 
m permeable mem-
brane (a total culture volume of 600 
 
 
 
l). After 5 d of culture, ac-
tivated T cells were transferred to 96 wells in triplicates (200 
 
 
 
l/
well) and cellular incorporation was determined after a 12-h pulse
with [
 
3
 
H]thymidine. To test suppression of secondary responses,
4 
 
 
 
 10
 
4
 
 DC1-primed CD8 T cells were restimulated in 96-well
round-bottom plates with allogeneic APC in the presence of
CD8 Tr cells at ratios of 1:1, 2:1, and 3:1. [
 
3
 
H]thymidine incor-
poration was determined after 3 d. In addition, culture superna-
tants were collected for quantitation of IFN-
 
 
 
.
 
Results
 
DC1 and DC2 Induce Strong Primary CD8 T Cell Prolifer-
ative Responses.
 
DC1 and DC2 were generated from puri-
fied monocytes or plasmacytoid precursors, respectively,
and activated with CD40 ligand. DC1 and DC2 expressed
similar levels of MHC class I, class II, endogenous class II– 
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associated peptides, and costimulatory molecules CD80 and
CD86 (Fig. 1 A). DC1 produced large amounts of IL-
12p70 starting as early as 12 h (116 
 
 
 
 48 pg/ml, 
 
n
 
 
 
  
 
2) and
reaching a peak at 24 h (1,225 
 
 
 
 63 pg/ml, 
 
n 
 
  
 
2) of
CD40 ligand stimulation. In contrast, DC2 maximally pro-
duced a mean value of 24.9 pg/ml of IL-12p70 at any time
point (6 h, 12 h, 24 h, and 48 h) after CD40 ligand stimu-
lation (Fig. 1 B). This indicates that the inability of mature
DC2 to produce large amounts of IL-12 is intrinsic to DC2
and not due to exhaustion after prolonged activation (29,
30). To investigate the ability of DC1 and DC2 to stimu-
late naive CD8 T cells, we cultured CD45RA
 
 
 
CD27
 
 
 
 na-
ive CD8 T cells with allogeneic DC1 and DC2. Both DC1
and DC2 induced strong proliferation of naive CD8 T cells
(Fig. 1
 
 
 
C).
 
DC2-primed CD8 T Cells Show Impaired Ability to Mount
Cytolytic and Secondary Proliferative Responses.
 
Whereas
CD8 T cells primed by DC1 were potent cytotoxic effec-
tors lysing allogeneic targets at low E/T ratios, CD8 T cells
primed with DC2 displayed poor alloantigen-specific cyto-
toxicity (Fig. 2 A), but expressed similar levels of perforin
and granzyme B (unpublished data). In addition, CD8 T
cells primed with DC1 responded strongly to secondary re-
stimulation with allogeneic DC1 or DC2, whereas CD8 T
cells primed with DC2 were hyporesponsive to secondary
restimulation with DC1 or DC2, as determined by pro-
liferation and blastogenesis (Fig. 2 B). However, DC2-
primed CD8 T cells were able to mount a proliferative
response to third-party alloantigens (Fig. 2 C). This is be-
cause in contrast to previously described IL-10–producing
Tr1 cell clones that display the same allo-specificity (7),
DC2-primed CD8 T cells derived from a 6-d primary cell
culture not only contain antigen-specific anergic CD8 T
 
cells, but also unprimed naive T cells with other specifici-
ties. Therefore, upon restimulation with the original al-
loantigen, DC2-primed anergic CD8 T cells will not pro-
liferate, whereas unprimed CD8 T cells specific to the
third-party alloantigen will undergo primary proliferation.
Indeed, in contrast to the secondary responses of DC1- or
DC2-primed CD8 T cells to the original alloantigen that
respectively produce cytokine IFN-
 
 
 
 or IL-10, their re-
sponses to the third-party alloantigen produce neither IFN-
 
 
 
,
nor IL-10 during the 48 h of stimulation, a feature of pri-
mary response (Fig. 2
 
 
 
D). These data indicate that DC2 in-
duce alloantigen-specific anergy of CD8 T cells, which dis-
play an impaired ability to mount cytolytic and secondary
proliferative responses.
 
DC2 Induce IL-10–producing CD8 T Cells.
 
We ana-
lyzed the cytokine production by primed CD8 T cells in
response to a 24-h restimulation with anti-CD3 plus anti-
CD28 (Fig. 3 A). CD8 T cells primed with anti-CD3 and
anti-CD28 for 6 d produced moderate levels of IFN-
 
 
 
(2,500–21,000 pg/ml) and TNF-
 
 
 
 (10–1,000 pg/ml), but
no IL-4, IL-5, nor IL-10. CD8 T cells primed with DC1
secreted high amounts of IFN-
 
 
 
 (9,000–39,000 pg/ml)
and TNF-
 
 
 
 (500–3,800 pg/ml), but no detectable IL-4,
IL-5, nor IL-10. CD8 T cells primed with DC2 secreted
significantly lower amounts of IFN-
 
 
 
 (400–9,500 pg/ml),
and neither IL4 nor IL5. Strikingly, DC2-primed CD8 T
cells produced significant amounts of IL-10 (120–230 pg/
ml). CD8 T cells primed with DC1, DC2, or anti-CD3
plus anti-CD28 did not secrete detectable levels of TGF-
 
 
 
protein. This was confirmed by quantitative PCR analyses
showing that no significant levels of TGF-
 
 
 
 mRNA were
detected in CD8 T cells primed with DC1 or DC2 after
restimulation. Immunofluorescence flow cytometry analy-
Figure 1. DC1 and DC2 express similar
levels of MHC products and costimulatory
molecules, but differ in their ability to pro-
duce IL-12. (A) Cell surface expression of
HLA-A2, HLA-DR, class II–associated
peptides (CLIP), CD80, and CD86 on DC1
and DC2. (B) IL-12p70 in the supernatants
of DC1 generated in a 5-d culture with
GM-CSF and IL-4 ( ) and DC2 generated
in a 5-d culture with IL-3 ( ) stimulated at
100,000 cells/ml with CD40 ligand–trans-
fected L cells for 6, 12, 24, and 48 h. Mean
value    SD of two independent experi-
ments are represented. (C) DC1 and DC2
induce strong proliferation of naive CD8 T
cells. Naive CD8 T cells were stimulated
with allogeneic CD40 ligand–activated
DC1 ( ) and DC2 ( ) and proliferative re-
sponses were assessed after 4, 5, 6, or 7 d.
Results are expressed as mean cpm   SD of
triplicate wells. Background [3H]thymidine
incorporation of CD8 T cells cultured in
the absence of DC remained  1,000 cpm at
all time points. 
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sis (Fig. 3
 
 
 
B, left) revealed that 40% of DC1-primed CD8
T cells and 15% of DC2-primed CD8 T cells, respectively,
differentiated into IFN-
 
 
 
–producing cells upon anti-CD3
plus anti-CD28 restimulation. DC2-primed CD8 T cells,
but not DC1-primed CD8 T cells, differentiated into
IL-10–producing cells (20%). In a separate experiment,
primed CD8 T cells were reactivated by a stronger stimu-
lus such as PMA plus ionomycin (Fig. 3
 
 
 
B, middle and
right). Although PMA plus ionomycin induced higher
numbers of IFN-
 
 
 
–producing CD8 T cells in all priming
conditions, it did not stimulate CD8 T cells to produce IL-4.
However, DC2-primed CD8 T cells produced IL-10 after
restimulation with PMA and ionomycin. Because DC1
produced 40–200 times more IL-12 than DC2 after CD40
ligand activation, we determined whether the generation
of IL-10–producing CD8 T cells was due to the absence of
IL-12. The addition of neutralizing monoclonal antibody
to IL-12 in the DC1–T cell culture significantly reduced
the ability of CD8 T cells to produce IFN-
 
 
 
, but did not
promote the generation of IL-10–producing CD8 T cells
(Fig. 4 A). The addition of IL-12 to the DC2–T cell cul-
ture strongly enhanced the IFN-
 
 
 
 production and, surpris-
ingly, the IL-10 production by CD8 T cells (Fig. 4 A).
Therefore, the ability of CD40 ligand–activated DC2 to
induce IL-10–producing CD8 T cells was not due to the
absence of IL-12.
Previous studies have shown that after a prolonged acti-
vation, DC1 (called exhausted DC) have a reduced ability
to prime Th1 responses (29, 30). Here, we determined if
the ability of DC to induce CD8 T cells to produce IL-10
was due to DC exhaustion by prolonged CD40 ligand acti-
vation. DC1 activated by CD40 ligand for either 1 or 6 d
Figure 2. DC2-primed CD8 T cells exhibit poor cytolytic activity and are hyporespon-
sive to secondary restimulation. (A) CD8 T cells were primed for 6 d with DC1 ( ,  )
and DC2 ( ,  ), and collected and tested for their ability to lyse allogeneic ( ,  ) or au-
tologous ( ,  ) B cells. The results represent six independent experiments. (B) CD8 T
cells primed with DC1 and DC2 for 6 d were collected and restimulated with DC1 and
DC2 derived from the donor used for priming. CD8 T cell expansion (upper panels), pro-
liferation (middle panels), and increase in cell size (lower panel) were determined after 3 d
of restimulation. Histograms represent CD8 T cell size before (filled) and after restimula-
tion (open histograms). The results represent three independent experiments. (C) CD8 T
cells from donor A were primed for 6 d with DC1 and DC2 from donor B, and then re-
stimulated with DC1 from donor B or donor C. Proliferation was determined after 3 d of
restimulation. (D) IFN-  and IL-10 in the supernatants of CD8 T cells, restimulated as de-
scribed in C for 2 d. 
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did not prime CD8 T cells to produce IL-10 (Fig. 4
 
 
 
B). In
contrast, DC2 activated by CD40 ligand for both 1 or 6 d
primed CD8 T cells to produce IL-10 (Fig. 4
 
 
 
B). In accor-
dance with the previous reports, DC1 activated by CD40
ligand for 6 d had a reduced ability to prime CD8 T cells to
produce IFN-
 
 
 
, compared with DC1 activated by CD40
ligand for 1 d (Fig. 4
 
 
 
B). Therefore, the ability of DC to
prime CD8 T cells to produce IL-10 is not due to DC ex-
haustion, but to an intrinsic property of DC2.
 
Impaired Secondary Responsiveness of DC2-primed CD8 T
Cells Is Mediated by IL-10.
 
To investigate whether IL-10
is responsible for the impaired secondary responsiveness of
Figure 3. DC2-primed CD8
T cells produce IL-10 and low
levels of IFN- . (A) Secretion of
IFN- , TNF- , IL-4, IL-5, and
IL-10 by CD8 T cells primed for
6 d with DC1, DC2, or anti-CD3
plus anti-CD28, and restimulated
with anti-CD3 plus anti-CD28
for 24 h. Each symbol represent
an independent experiment. (B)
Two-color staining of intracellu-
lar IFN-  and IL-10, or IL-4 and
IL-10, produced by DC1- and
DC2-primed CD8 T cells after a
5-h restimulation with anti-CD3
plus anti-CD28 (left), or PMA
plus ionomycin (middle and
right). 104 cells were analyzed
and the percentages of each pop-
ulation are indicated in the plots. 
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DC2-primed CD8 T cells, neutralizing anti–IL-10 mAbs
were added into the DC2–CD8 T cell coculture. The ad-
dition of anti–IL-10 mAbs resulted in the generation of
CD8 T cells that did not produce IL-10 upon restimula-
tion and became strongly cytotoxic and responsive to
secondary restimulation (Fig. 5). DC2 do not produce de-
tectable IL-10 mRNA and protein after CD40 ligand ac-
tivation (25), which suggests that IL-10 produced by CD8
T cells has an autocrine effect on the differentiation of
IL-10–producing CD8 T cells. Furthermore, the data indi-
cate that IL-10–producing CD8 T cells mediated the sec-
ondary cytolytic and proliferative hyporesponsiveness of
DC2-primed CD8 T cells. Blocking of IL-10 during the
secondary restimulation did not enhance the proliferative
response of DC2-primed CD8 T cells (unpublished data),
indicating that the hyporesponsiveness was induced during
the primary cocultures.
 
IL-10–producing CD8 T Cells Strongly Suppress Naive
CD8 T Cell Responses.
 
To determine whether IL-10–
producing CD8 T cells are immunosuppressive, CD8 T
cells cultured with allogeneic DC2 for 6 d were added into
a coculture of autologous naive CD8 T cells with APCs
from the same donor of priming DC2. DC2-primed CD8
Tr cells strongly inhibited the proliferation of naive CD8 T
cells to allogeneic monocytes in a dose-dependent fashion
(Fig. 6, A and B). CD8 Tr cells also inhibited naive CD8 T
cell proliferation to immature and mature DC1 (Fig. 6, C
and D, respectively).
 
CD8 Tr Cells Suppress Naive CD8 T Cell Proliferation
through IL-10, but Not TGF-
 
 
 
.
 
Previous studies demon-
strated that CD4 regulatory T cells or CD4 Th3 cells sup-
press T cell–mediated immune responses, respectively,
through IL-10 or TGF-
 
 
 
 (4, 7). To further investigate
whether IL-10 or TGF-
 
 
 
 was involved in the immunosup-
pression by CD8 Tr cells, neutralizing antibodies to IL-10
or TGF-
 
 
 
 were added, respectively, into naive CD8 T cell
coculture with allogeneic APCs and syngeneic CD8
Tr cells. Anti–IL-10, but not anti–TGF-
 
 
 
, completely
blocked the inhibitory effect of CD8 Tr cells (Fig. 7 A), in-
dicating that the suppression was mediated by IL-10. The
antibody against TGF-
 
 
 
 used in the neutralization experi-
ments is a monoclonal mouse anti–TGF-
 
 
 
1, -
 
 
 
2, -
 
 
 
3 and
recognizes human TGF-
 
 
 
1 and TGF-
 
 
 
2. Its neutralization
potential has been previously described (detailed in the
manufacturer’s instruction). This was further confirmed by
the finding that the inhibitory effect of CD8 Tr cells could
be mimicked by the addition of low doses of IL-10 in cul-
tures (Fig. 7 A) and the fact that CD8 T cells activated by
DCs do not produce detectable levels of TGF-
 
 
 
.
CD8 Tr cells primed by DC2 from donor B only inhib-
ited naive CD8 T cell proliferation induced by APCs from
donor B, but not APCs from donor C (Fig. 7 B). These
Figure 4. The generation of IL-10–producing CD8 T cells is not due
to the absence of IL-12 nor to DC exhaustion caused by prolonged
CD40 ligand activation. (A) Cytokine secretion by CD8 T cells primed
for 6 d with DC1 plus neutralizing anti–IL-12, DC2, or DC2 plus IL-12.
(B) Cytokine production of CD8 T cells primed for 6 d with DC1 and
DC2 activated with CD40 ligand for either 1 d (5 d of GM-CSF/IL-4 or
IL-3, respectively, plus an additional day of CD40 ligand), or 6 d (6 d of
GM-CSF/IL-4 or IL-3, respectively, in the presence of CD40 ligand).
Figure 5. IL-10 is required for
the generation of IL-10–produc-
ing CD8 T cells and mediates the
poor cytolytic activity and sec-
ondary hyporesponsiveness of
DC2-primed CD8 T cells. (A)
Cytokine profile of CD8 T cells
primed for 6 d with DC1, DC2,
or DC2 plus neutralizing anti–
IL-10 (10  g/ml). (B) CD8 T
cells primed with DC1 ( ), DC2
( ), or DC2 plus anti–IL-10 ( )
were tested for the ability to lyse
allogeneic B cells in a 5-h Cr-
release assay. Specific lysis of au-
tologous B cells remained below
15% in all conditions (unpub-
lished data). (C) Secondary pro-
liferation of CD8 T cells primed
with DC1, DC2, or DC2 plus
anti–IL-10 after a 3-d restimula-
tion with DC2. Equivalent results
were obtained by restimulation
with DC1 (unpublished data).
Results are representative of three
independent experiments. 
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data indicate that immunosuppression requires antigen-spe-
cific restimulation of CD8 Tr cells to produce IL-10.
 
CD8 Tr Cells Can Inhibit Bystander Activation of Naive T
Cells through IL-10.
 
To investigate whether CD8 Tr cells
have the ability to inhibit bystander CD8 T cell prolifera-
tion, transwell culture experiments were performed in
which CD8 Tr cells were separated from primary naive
CD8 T cells by permeable membranes (Fig. 7
 
 
 
C). CD8
Tr cells reactivated by the priming APCs in the upper
well strongly inhibited the proliferation of naive CD8 T
cells in response to a third-party APC in the lower wells.
The addition of anti–IL-10 mAbs completely blocked the
inhibition effects. These data suggest that CD8 Tr cells
have the ability to inhibit bystander activation of naive
CD8 T cells if the site of activation of CD8 Tr cells is
close enough to deliver secreted IL-10 to the adjacent na-
ive T cells. Because IL-10 is known to inhibit the prolif-
eration of naive CD4 T cells (28), bystander suppression
of CD4 T cells may also occur when CD8 Tr cells are si-
multaneously activated to produce IL-10 by the same or
an adjacent APC.
 
CD8 Tr Cells Cannot Suppress Preactivated CD8 T
Cells.
 
To test whether CD8 Tr cells could inhibit preacti-
vated CD8 T cells, different numbers of DC2-primed CD8
Tr cells were added to a coculture of autologous DC1-pre-
activated CD8 T cells with APCs. As shown in Fig. 8,
 
 
 
A
and B, CD8 Tr cells were unable to suppress both the pro-
liferative responses and the IFN-
 
  
 
secretion of activated
DC1-primed CD8 T cells. The increased proliferation and
IFN-
 
 
 
 production detected in cultures with increasing
numbers of CD8 Tr cells may simply reflect the additive
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Discussion
 
During the last three decades, there have been extensive
efforts to understand the cellular and molecular mecha-
nisms underlying CD8 T cell–mediated immunosuppres-
sion. Hypothetical suppressor cascades, involving the par-
ticipation of multiple effector T cell subsets and a variety of
secreted mediators, have been proposed (31–33). These
models have not been confirmed due to the difficulties in
isolating the primary CD8 T suppressor cells, the failure in
characterizing the soluble suppressive factors, and the in-
ability to convincingly explain the induction and antigen
specificity of CD8 T cell–mediated suppression (19, 20).
In this study, we describe the generation of a population
of CD8 Tr cells from naive CD8 T cells during a 6-d cul-
ture with mature lymphoid DC2. These primary CD8 Tr
cells, which represent 10–20% of primed CD8 T cells, can
now be directly visualized by immunofluorescence flow
cytometry according to intracellular expression of IL-10. In
addition, we have demonstrated that IL-10 represents the
soluble inhibitory factor, which is responsible for the poor
cytolytic and secondary hypoproliferative responses, as well
as for the suppression of primary naive CD8 T cell re-
sponses. IL-10–producing CD8 Tr cells are very potent,
because one IL-10–producing CD8 Tr cell can actually
suppress the proliferation of 10 to 20 naive CD8 T cells.
Previous models of CD8 T cell–mediated immunosuppres-
sion, based on inducer and effector T suppressor cells with
distinct T cell determinants, failed to provide a solid basis
for the antigen specificity of suppression (19). Our present
study demonstrates that IL-10–producing CD8 Tr cells are
directly induced via antigen presentation by DC2 and re-
quire antigen-specific restimulation to deliver their immu-
nosuppression through the production of IL-10. Therefore,
Figure 6. DC2-primed CD8 T cells inhibit primary
CD8 T cell proliferation induced by various types of
APCs, in a dose-dependent manner. (A) Primary CD8
T cell proliferation in response to allogeneic monocytes
in the presence of increasing numbers of syngeneic
DC2-primed CD8 Tr cells ( ). Primary proliferation
of naive CD8 T cells without CD8 Tr ( ) and prolif-
eration of CD8 T regulatory cells ( ) are also repre-
sented. (B) Proliferation of CD8 T cells stimulated
with allogeneic monocytes, (C) immature DC1, or (D)
mature DC1 in the presence of equal numbers of
CD8 Tr (1:1 ratio). Results are representative of two
independent experiments. 
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this study provides direct experimental evidence for the ex-
istence of CD8 Tr cells, identifies IL-10 as soluble inhibi-
tory factor, and explains the antigen specificity of CD8 T
cell–mediated immunosuppression.
A subset of CD8 T suppressor cells lacking CD28 ex-
pression has been reported (16, 34). IL-10–producing
CD8 Tr cells differ from CD28 CD8 T cells in several as-
pects. Whereas IL-10–producing CD8 Tr cells can be di-
rectly generated from naive CD8 T cells by one round of
stimulation with DC2, CD28 CD8 T suppressor cells ap-
pear to represent end-stage CTL differentiation after re-
petitive stimulation (35). Furthermore, IL-10–producing
CD8 Tr cells inhibit primary T cell responses through IL-
10, whereas CD28 CD8 T suppressor cells inhibit the
ability of APC to induce T cell activation by direct cell
contact (34). Therefore, there may be two distinct subsets
of CD8 Tr suppressor cells that are responsible for CD8 T
cell–mediated immunosuppression at different stages of
Figure 7. Suppression is mediated by soluble IL-10 and requires Ag-specific stimulation
of IL-10 CD8 Tr cells. (A) 5-d primary CD8 T cell proliferation induced by allogeneic
monocytes plus equal numbers of CD8 Tr cells in the presence or absence of neutralizing
anti–IL-10 or anti–TGF- . To determine if IL-10 could display a similar inhibitory effect of
CD8  Tr cells, primary CD8 T cell proliferation induced by allogeneic monocytes was
performed in the presence of IL-10, or IL-10 plus anti–IL-10. The stimulation index of naive
CD8 T cells was calculated by the following formula: cpm [(naive T   T reg   mono)  
(T reg   mono)]/cpm (naive T). Results are representative of three independent experi-
ments. (B) Naive CD8 T cells (donor A) were stimulated with allogeneic monocytes from
donor B or C in the presence of CD8 Tr cells primed to donor B or C. Results are repre-
sentative of two independent experiments. (C) CD8 Tr cells stimulated separately with
monocytes were added to the primary cultures of naive CD8 T cells plus monocytes in
Transwell chambers. The stimulation index of naive CD8 T cells was calculated by the
following formula: cpm (naive T   mono)/cpm (naive T).
Figure 8. CD8 Tr cells do not suppress secondary re-
sponses. (A) 3-d secondary proliferation and (B) IFN- 
production by DC1-primed CD8 T cells induced by allo-
geneic monocytes plus CD8 Tr cells (1:1, 1:2, and 1:4 ra-
tio). The stimulation index of naive CD8 T cells was cal-
culated by the following formula: cpm [(DC1   T   T
reg   mono)   (T reg   mono)]/cpm (DC1   T).703 Gilliet and Liu
immune response and by different mechanisms. IL-10–
producing CD8 Tr cells share many similarities with the
CD4 Tr1 cells (7): (a) they are both anergic; (b) their gen-
eration depends on IL-10; and (c) they both suppress pri-
mary T cell responses through IL-10, but not through
TGF- . Therefore, this study suggests that IL-10-produc-
ing regulatory cells exist both in CD4 and CD8 T cell
compartments.
A recent study described IL-10–producing CD8 T cells
in vivo in concomitance with a decreased influenza-specific
CD8 T cell response after vaccination with immature DC1
pulsed with influenza matrix peptide (36). Although the
function of these anti-influenza IL-10–producing CD8 T
cells was not characterized, this study suggests that IL-10–
producing CD8 Tr cells may indeed exist and operate in
vivo. Furthermore, the existence of IL-10–producing CD8
Tr cells in vivo has been suggested in a long-term acceptor
of allogeneic kidney transplant (37).
We showed that DC2-primed CD8 Tr cells are unable
to suppress secondary responses of activated effector cells
such as DC1-primed CD8 T cells. This finding does not
exclude the possibility that CD8 Tr cells may suppress sec-
ondary responses of quiescent memory T cells, as described
in a recent study (36)
Our study further demonstrates the functional differ-
ences between CD40 ligand–activated mature DC1 and
DC2, which induce strong IFN- –producing cytotoxic
CD8 T cells and IL-10–producing CD8 Tr cells, respec-
tively. During bone marrow transplantation or solid organ
transplantation, it is likely that donor or host DCs are acti-
vated by CD40 ligand expressed by allogeneic T cells.
CD40 ligand–activated DC1 may induce strong IFN- –
producing alloantigen-specific Th1 and CTL responses,
which will trigger and accelerate GVHD or graft rejection.
In contrast, CD40 ligand–activated DC2 may induce Th2
(25) and IL-10–producing CD8 Tr cells, which will inhibit
GVHD or graft rejection. This hypothesis is supported by a
recent study showing that transplantation of GM-CSF–
mobilized blood cells, which contain increased numbers of
DC2 precursors, induced less severe GVHD (38). The
study suggests that transplanted DC2 precursors may cap-
ture host alloantigen, mature into DC2, and present the
host alloantigen to tolerize the donor T cell by the induc-
tion of Th2 (25) and IL-10–producing CD8 Tr cells.
Therefore, DC2 lineage may play a key role in transplanta-
tion-associated immunological tolerance.
The generation of primary IL-10–producing CD8 Tr
cells provides the direct evidence supporting the immuno-
logical paradigms of CD8 T cell–mediated immunosuppres-
sion. Further understanding of the molecular mechanism
regulating the generation of CD8 Tr cells by human-mature
DC2 may have important clinical implications for the de-
velopment of more effective therapies for autoimmune and
transplantation-associated diseases.
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